CN2833596Y - Submersible ovary tumor self-diagnosis strip - Google Patents
Submersible ovary tumor self-diagnosis strip Download PDFInfo
- Publication number
- CN2833596Y CN2833596Y CN 200520086451 CN200520086451U CN2833596Y CN 2833596 Y CN2833596 Y CN 2833596Y CN 200520086451 CN200520086451 CN 200520086451 CN 200520086451 U CN200520086451 U CN 200520086451U CN 2833596 Y CN2833596 Y CN 2833596Y
- Authority
- CN
- China
- Prior art keywords
- urine
- glass tube
- test strips
- fixed head
- wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a submersible ovary tumor self-diagnosing meter, which is composed of a urine CA 125 testing paper strip 1 and a fixing plate 2, wherein the urine CA 125 testing paper strip 1 is bonded on one side of the fixed plate 2, the urine CA 125 testing paper strip 1 and the fixing plate 2 are simultaneously inserted in a glass tube 3, the lower end of which is fixedly provided with an upper dropping ball 4, an upper floating ring 5 is sheathed on the outer wall of the glass tube 3, the fixed position of the floating ring 5 on the glass tube is consistent with an antibody detecting line 6 on the urine CA 125 testing paper strip 1 and a urine entering hole 7 is arranged on the wall of the glass tube 3 below the floating ring 5. The submersible ovary tumor self-diagnosing meter not only is favorable for women to diagnose the CA 125 level of urine in time by themselves, but also compared with the present testing paper strip to be used, the utility model is more favorable to operation, users can control the depth of the submersible ovary tumor self-diagnosing meter inserted in the urine, and the utility model can make the urine stabilized on the level of the antibody detecting line and enhances the self-diagnosing speed and effect.
Description
Technical field
The utility model relates to a kind of ovarian neoplasm pick-up unit, particularly a kind of floatable ovarian neoplasm table of testing oneself.
Technical background
The early diagnosis of ovarian neoplasm is the important prerequisite condition that improves the patients with ovarian tumor survival rate, clinical data proves, for the malignant ovarian tumor patient, owing to just mostly be late period when finding, promptly be to have passed through operation, chemotherapy and radiation, the survival rate in 5 years also only is 28%, if the energy early diagnosis, early operation and treatment can make the survival rate in 5 years improve about 20%.Studies have shown that: the CA in the serum
125Can be used as the mark of malignant tumor of ovary, can have early diagnosis and detect treatment function, if can make the numerous women interior CA of body that tests oneself in time
125Level will help to improve early diagnostic rate.At present, clinically to CA
125Mensuration generally be to chemically examine detection by collecting blood sample because the patient often just takes a blood sample when symptom is arranged, thus also III-IV phase of ovarian neoplasm often of this chemical examination detection, detected change of serum C A
125Value reached level mostly (normal value<35u/ml) be not so reached the purpose of early diagnosis greater than 400u/ml; For early diagnosis, the employing that has measure urine CA
125Test strips, this test strips applicable numerous women, especially childbearing age and postmenopausal women can urinate CA timely and conveniently
125Level is tested oneself, by the CA in the urine
125The mensuration of level can be found ovarian neoplasm early, this urine CA
125The structure of test strips (is set at 〉=35u/ml) constitute monoclonal antibody OC by supporting baseplate, test lead protective seam, water accepting layer, suction line and handheld terminal protective seam, water accepting layer and Jin Biaokangtiqu, nitrocellulose filter, antibody detection line
125Two antiantibody detection lines are coated with and invest on the nitrocellulose filter, and detected value is set at CA
125〉=35u/ml, monoclonal antibody OC
125Be to carry out hybridoma with ovarian epithelium JEG-3 OVCA433 to cultivate the antibody that the back is obtained, specific antigen CA that can specific identification epithelial ovarian cancer
125, when using this test strips, arrest handheld terminal, the test side is inserted in the urine, make the urine face be on the antibody detection line monoclonal antibody OC
125CA in gold-marking region and the urine sample
125Antigen generation antigen-antibody idiosyncrasy, and under the nitrocellulose filter capillary sample effect absorption of connected drying, CA in developer on the nitrocellulose filter and the urine
125Antigen moves up along it, moves to the monoclonal antibody OC that scribbles on the nitrocellulose filter
125During two anti-zones, CA in the urine
125Antigen is by the monoclonal antibody OC in the antibody detection line
125If identification is CA
125〉=35u/ml, then antibody detection line is shown in red, and CA in the depth of color and the urine
125Content is proportional, therefore, utilize this test strips can find ovarian neoplasm early, but the weak point that exists is: inconvenient operation, can accurately not control the degree of depth inserted in the urine, be on the antibody detection line just in time to make the urine face, simultaneously, when arresting handheld terminal with hand, rock easily, cause the insertion depth instability of test strips.
Summary of the invention
The purpose of this utility model is to provide a kind of can accurately control the degree of depth of inserting in the urine, and the urine face is stabilized on the antibody detection line, and need not manually-operated, is convenient to floatable ovarian neoplasm that the women tests oneself the at any time table of testing oneself.
For reaching above purpose, the technical scheme that the utility model adopted is: this floatable ovarian neoplasm table of testing oneself, and by urine CA
125Test strips, fixed head constitute, urine CA
125Test strips is bonded in a side of fixed head, it is characterized in that urinating CA
125Test strips and fixed head are inserted in the glass tube simultaneously, the fixing upper sinking-ball in the lower end of glass tube, water wing on suit on the outer wall of glass tube, water wing fixed position and the CA on glass tube
125Antibody detection line unanimity on the test strips is provided with urine and enters the hole on the glass tube walls below the water wing.The utility model is also implemented by following measure: described heavy ball is the hollow glass spheroid, with the disposable integral body of making of glass tube, in the hollow glass spheroid iron sand is housed, so that can be upright after inserting in the urine; Described water wing is a ring-shaped gasbag, inwall is stuck in the ring-type triangular groove support, the interior drift angle of ring-type triangular groove support is bonded on the outer wall of glass tube, glass tube can be floated on the one hand, do not influence the observation that antibody detection line changes on the other hand, the buoyancy of water wing is greater than the gravity of heavy ball, and when making glass tube vertically insert in the urine, water wing floats on the urine face; Described fixed head is the strip plastic plate, its width is consistent with the diameter of glass tube, so that being inserted in the glass tube, can stablize by fixed head, fixed disc is established in upper end at fixed head, the diameter of fixed disc is consistent with the diameter of glass tube, on the fixed disc upper face, establish and carry handle, on the wall of fixed disc, also establish air hole, when inserting or propose fixed head and changing urine CA
125During test strips, can arrest and propose the handle operation; Described urine CA
125Test strips is a known technology, by water accepting layer, antibody detection line, the plain film of nitric acid and monoclonal antibody OC
125Gold-marking region constitutes.
The beneficial effects of the utility model are: not only help the women CA in the urine that in time tests oneself
125Level, and compare with the test strips of present use, more helping operation, its degree of depth of inserting in urine can be controlled voluntarily, and can make urine be stabilized in the antibody detection line level, improves test oneself speed and effect.
Description of drawings
Fig. 1 looks synoptic diagram for the utility model structure master.
Fig. 2 is that the utility model is along the A-A cross-sectional schematic.
Embodiment
Make the utility model with reference to accompanying drawing 1,2.This floatable ovarian neoplasm table of testing oneself is by urine CA
125Test strips 1, fixed head 2 constitute, urine CA
125Test strips 1 is bonded in a side of fixed head 2, urine CA
125Test strips 1 and fixed head 2 are inserted in the glass tube 3 simultaneously, the fixing upper sinking-ball 4 in the lower end of glass tube 3, and water wing 5 on suit on the outer wall of glass tube 3, the fixed position of water wing 5 on glass tube 3 and urine CA
125 Antibody detection line 6 unanimities on the test strips 1 are provided with urine and enter hole 7 on glass tube 3 walls of water wing below 5.Described heavy ball 4 is the hollow glass spheroid, with the glass tube 3 disposable integral body of making, iron sand 8 is housed in the hollow glass spheroid, so that can be upright after inserting in the urine; Described water wing 5 is a ring-shaped gasbag, inwall is stuck in the ring-type triangular groove support 9, and the interior drift angle of ring-type triangular groove support 9 is bonded on the outer wall of glass tube 3, and the buoyancy of water wing 5 is greater than the gravity of heavy ball 4, when making in the glass tube 3 vertical insertion urines, water wing 5 floats on the urine face; Described fixed head 2 is the strip plastic plate, its width is consistent with the diameter of glass tube 3, establish fixed disc 10 in the upper end of fixed head 2, the diameter of fixed disc 10 is consistent with the diameter of glass tube 3, on fixed disc 10 upper faces, establish and carry handle 11, on the wall of fixed disc 10, also establish air hole 12, when inserting or propose fixed head 2, can arrest and propose handle 11 operations; Described urine CA
125Test strips 1 is a known technology, by water accepting layer 1a, antibody detection line 6, nitrocellulose filter 1b and monoclonal antibody OC
125Gold-marking region 1c constitutes.
Claims (4)
1, a kind of floatable ovarian neoplasm table of testing oneself is by urine CA
125Test strips (1), fixed head (2) constitute, urine CA
125Test strips (1) is bonded in a side of fixed head (2), it is characterized in that urinating CA
125Test strips (1) and fixed head (2) are inserted in the glass tube (3) simultaneously, the fixing upper sinking-ball (4) in the lower end of glass tube (3), water wing on suit on the outer wall of glass tube (3) (5), the fixed position of water wing (5) on glass tube (3) and urine CA
125Antibody detection line (6) unanimity on the test strips (1) is provided with urine and enters hole (7) on glass tube (3) wall below the water wing (5).
2, the floatable ovarian neoplasm according to claim 1 table of testing oneself is characterized in that described heavy ball (4) is the hollow glass spheroid, with the disposable integral body of making of glass tube (3), is equipped with iron sand (8) in the hollow glass spheroid.
3, the floatable ovarian neoplasm according to claim 1 table of testing oneself is characterized in that described water wing (5) is a ring-shaped gasbag, and inwall is stuck in the ring-type triangular groove support (9), and the interior drift angle of ring-type triangular groove support (9) is bonded on the outer wall of glass tube (3).
4, the floatable ovarian neoplasm according to claim 1 table of testing oneself, it is characterized in that described fixed head (2) is the strip plastic plate, its width is consistent with the diameter of glass tube (3), establish fixed disc (10) in the upper end of fixed head (2), the diameter of fixed disc (10) is consistent with the diameter of glass tube (3), on fixed disc (10) upper face, establish and carry handle (11), on the wall of fixed disc (10), also establish air hole (12).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200520086451 CN2833596Y (en) | 2005-08-26 | 2005-08-26 | Submersible ovary tumor self-diagnosis strip |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200520086451 CN2833596Y (en) | 2005-08-26 | 2005-08-26 | Submersible ovary tumor self-diagnosis strip |
Publications (1)
Publication Number | Publication Date |
---|---|
CN2833596Y true CN2833596Y (en) | 2006-11-01 |
Family
ID=37197908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200520086451 Expired - Fee Related CN2833596Y (en) | 2005-08-26 | 2005-08-26 | Submersible ovary tumor self-diagnosis strip |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN2833596Y (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108459017A (en) * | 2018-05-21 | 2018-08-28 | 张军芬 | Test strip |
-
2005
- 2005-08-26 CN CN 200520086451 patent/CN2833596Y/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108459017A (en) * | 2018-05-21 | 2018-08-28 | 张军芬 | Test strip |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102980998A (en) | High-flux microfluidics paper chip for instantly and quickly detecting multiple human tumor markers | |
CN105784691B (en) | Nitrogen dioxide device for fast detecting and detection method | |
CN113848323A (en) | Column pushing type sampling detection integrated rapid detection structure and application thereof | |
CN201765226U (en) | Dial type direct-reading fully-automatic immune luminescence analysis system | |
CN206756851U (en) | A kind of human-body fatigue condition checkout gear | |
CN2833596Y (en) | Submersible ovary tumor self-diagnosis strip | |
CN105445454A (en) | Quantifiable immunochromatography device | |
CN107037208B (en) | A kind of Multifunctional fluorescent immunochromatographirapid rapid quantitative detection card | |
CN106525664A (en) | Automatic testing equipment for capillary effect | |
CN101373188A (en) | Tumor-associated antigen 19-9 chemical luminescence immune analytic determination reagent kit and preparation method thereof | |
CN205484361U (en) | Detect kit of hepatitis E virus igM antibody | |
CN204177806U (en) | A kind of immunity-chromatography test strip | |
CN207472899U (en) | A kind of kit for quantitatively detecting NGAL in urine or blood | |
CN207502542U (en) | A kind of detection kit for colloidal gold method | |
CN104569300A (en) | Detection device for analyzed substances in liquid sample | |
CN216117640U (en) | Sampling and detection integrated rapid detection structure | |
CN109444406A (en) | Test strips of quantitative detection marker cyfra21-1 and preparation method thereof and detection method | |
CN212364302U (en) | Automatic operating detection self-sealing urine measuring tube | |
CN104597257A (en) | Rapid myoglobin detection method and corresponding detection kit | |
CN210198439U (en) | Electromagnetic flow velocity and water depth integrated open channel flowmeter | |
CN205246656U (en) | In vitro diagnostic reagent kit | |
CN208912102U (en) | Chemiluminescence micro-fluidic chip based on magnetic bead | |
CN205958464U (en) | Domestic urine detection appearance | |
CN205176037U (en) | Can quantitative immunity chromatography device | |
CN203275408U (en) | Kit for detecting free prostate specific antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |